Suda Pharmaceuticals Ltd Shares float
What is the Shares float of Suda Pharmaceuticals Ltd?
The Shares float of Suda Pharmaceuticals Ltd is 421.155M 109.49%
What is the definition of Shares float?
Shares float is the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock.
= annual shares outstanding - closely held shares
Shares float represents the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock held by promoters, company officers, controlling-interest investors, or government. This number is sometimes seen as a better way of calculating market capitalization because it provides a more accurate reflection of what public investors consider the company to be worth. In this context, the float may refer to all the shares outstanding that can be publicly traded
The float is calculated by subtracting the locked-in shares from outstanding shares. Stocks with smaller floats tend to be more volatile than those with larger floats. In general, the large holdings of founding shareholders, corporate cross-holdings, and government holdings in partially privatized companies are excluded when calculating the size of a public float.
Shares float of companies in the Health Care sector on ASX compared to Suda Pharmaceuticals Ltd
What does Suda Pharmaceuticals Ltd do?
Suda Pharmaceuticals Ltd engages in the development of drug delivery technology in Australia, India, Europe and Korea. It offers ZolpiMist, an oro-mucosal spray formulation of zolpidem tartrate marketed under the brand name of Ambien or Stilnox, a non-benzodiazepine prescribed for the short-term treatment of insomnia. The company's product pipeline includes Sumatriptan, an oral spray formulation for the treatment of acute migraine; and anagrelide, a platelet lowering agent for use in thrombosis, which is used for the treatment of cancer. Suda Pharmaceuticals Ltd has license and supply agreement with Teva Pharmaceuticals International GmbH and Mitsubishi Tanabe Pharma Singapore for ZolpiMist oral spray; product development, licence, and supply agreement with Cann Pharmaceutical Australia Ltd for the development of novel oral spray of pharmaceutical-grade cannabinoid derivatives for the treatment of drug resistant epilepsy, melanoma, and motion sickness; and feasibility and option agreement with Zelira Therapeutics for the use of cannabinoids for a range of uses, including insomnia, autism, opioid reduction, anxiety, pain, and cancer. The company also has a feasibility study and option agreement with Laboratorios Ordesa, S.L. The company was formerly known as Suda Limited and changed its name to Suda Pharmaceuticals Ltd in November 2017. Suda Pharmaceuticals Ltd was incorporated in 1999 and is headquartered in Osborne Park, Australia.
Companies with shares float similar to Suda Pharmaceuticals Ltd
- Base Resources has Shares float of 420.154M 35.67%
- Intra has Shares float of 420.491M 92.24%
- IMS has Shares float of 420.500M 42.05%
- Huarchi Global has Shares float of 420.580M 21.03%
- Clean Power Capital has Shares float of 420.661M 94.27%
- AbraPlata Resource has Shares float of 421.006M 91.77%
- Suda Pharmaceuticals Ltd has Shares float of 421.155M 109.49%
- MSM International has Shares float of 421.544M 50.04%
- New World Department Store China has Shares float of 421.570M 25.00%
- Fountain Set () has Shares float of 422.059M 34.45%
- SBI Life Insurance has Shares float of 422.069M 42.17%
- Biocon has Shares float of 422.508M 35.21%
- Kier Plc has Shares float of 422.684M 94.71%